Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness of JNJ-18054478 measured by the
percent change from baseline in Forced Expiratory Volume in one Second (FEV1) after 12 weeks
of therapy in patients with persistent asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.